DUBLIN--(BUSINESS WIRE)--Dec 5, 2018--The "Global Blood Transfusion Diagnostics Market - Forecasts from 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The global blood transfusion diagnostics market is expected to grow at a CAGR of 5.48% during the forecast period of 2017-2023. The rise in the market may be attributed to the rising number of infectious diseases coupled with the rise in demand for blood and blood components transfusions owing to large patient population base suffering from diseases such as aplastic anemia, thalassemia, and leukemia.Rising incidences of the chronic diseases requiring blood transfusions is further expected to drive demand for blood transfusion diagnostics. As per report by WHO, haemoglobin disorders (sickle-cell disorders and thalassemia's) were originally endemic in 60% of 229 countries, potentially affecting 75% of births, but are now sufficiently common in 71% of countries among 89% of births.However, lack of skilled professionals for the blood transfusion diagnostics may hamper the growth of the market during the given forecast period.
Major industry players profiled as part of the report are F. Hoffmann-La Roche Ltd., Diagast and Abbott among others.
By Product Type
InstrumentsKits & Reagents
ELISAWestern BlottingNucleic Acid AmplificationOthers
Hospitals and ClinicsDiagnostic LabsBlood Banks
North AmericaSouth AmericaEuropeMiddle East and AfricaAsia Pacific
Key Topics Covered
2. Research Methodology
3. Key Findings of the Study
4. Market Dynamics
5. Global Blood Transfusion Diagnostics Market Forecast by Type
6. Global Blood Transfusion Diagnostics Market Forecast by Technology
7. Global Blood Transfusion Diagnostics Market Forecast by End-User
8. Global Blood Transfusion Diagnostics Market Forecast by Geography
9. Competitive Intelligence
10. Company Profiles
Quotient Ltd.BAG Health CareAbbottImmucorDiasorin SPABio-Rad Laboratories Inc.Grifols Australia Pty Ltd.F. Hoffmann-La Roche Ltd.Beckman Coulter Inc.Diagast
For more information about this report visit https://www.researchandmarkets.com/research/78rbvd/global—blood?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20181205005304/en/
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:Blood Banking
INDUSTRY KEYWORD: HEALTH OTHER HEALTH
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 12/05/2018 05:14 AM/DISC: 12/05/2018 05:14 AM